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Résumé de Synthèse 
Prévalence des maladies inflammatoires de l'intestin: Une étude de 
cohorte sur la population du canton de Vaud (Suisse). 
1. Introduction 
Etant donné l'évolution constante des donnés épidémiologiques sur les maladies 
inflammatoires chroniques de l'intestin (MICI), nous avons recherché à caractériser la 
prévalence de la maladie de Crohn (MC) et de la colite ulcéreuse (CU) dans une 
population définie de la Suisse. 
2. Méthodes 
Nous avons identifiés, dans une population délimitée au Canton de Vaud, les 
patients adultes atteints de maladies inflammatoires de l'intestin en regroupant les 
données histologiques et médicales disponibles à l'hôpital et au cabinet du 
gastroentérologue. 
Pour nos analyses, nous avons utilisé la méthode de la régression de Poisson afin 
d'identifier les facteurs démographiques significativement liés avec la prévalence. 
Ensuite, nos résultats ont été comparés aux valeurs de prévalence des MICI issues 
d'autres études de population (revue systématique de la littérature) afin de dégager 
les tendances de leur évolution au cours du temps. 
3. Résultats 
La prévalence des MICI pondérée selon l'âge et le sexe était de 205.7 cas (100.7 
MC et 105.0 CU) pour 105 habitants. Parmi les 1016 patients identifiés (519 MC et 
497 CU), les femmes étaient plus représentées que les hommes dans la MC 
(P<0.0001), alors que la proportion d'hommes dépassait celle des femmes chez les 
patients âgés atteints de CU (p=0.008). Par conséquent, le fait d'être un homme était 
statistiquement associé à la CU (Risque relatif (RR) 1.25, p=0.013), et celui d'être 
une femme était associé à la MC (RR 1.27; p=0.007). L'étude a également montré 
qu'habiter en zone urbaine était significativement associé avec les deux types de 
MICI (RR (MC) 1.49; p<0.001, (CU) 1.63; p<0.001). Enfin, il a été mis en évidence 
dans les pays industrialisés, entre 1960 et 2005, une augmentation annuelle des 
taux de prévalences de 2.4% (95% IC, 2.1 %-2.8%; p<0.001) pour la MC et de 3.6% 
(95% IC, 3.1 %-4.1 % ; p<0.001) pour la CU. 
4. Conclusion 
L'extrapolation de nos données au niveau Suisse fournit une estimation de 12 000 
cas de MICI pour le pays soit 1 cas pour 500 habitants. 
Notre étude contribue également à démontrer une augmentation de la prévalence 
des MICI en Europe. 
Mots clés: 
Maladie de Crohn, colite ulcéreuse, maladies inflammatoires chroniques de l'intestin, 
épidémiologie, revue de littérature. 
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Abstract 
Background and aims: Because of the changing epidemiology of lnflammatory Bowel Diseases 
(IBD), we set out to characterize the population-based prevalence of Crohn's Disease (CD) and 
Ulcerative Colitis (UC) in a defined population of Switzerland. 
Methods: Adult IBD patients were identified by a cross-matched review of histological, hospital and 
gastroenterologist files throughout a geographical defined population (Canton of Vaud). 
Demographic factors statistically significantly associated with prevalence were evaluated using a 
stepwise Poisson regression analysis. Results were compared to IBD prevalence rates in other 
population·based studies and time trends were performed, based on a systematic literature review. 
Results: Age and sex-adjusted prevalence rates were 205. 7 IBD (1OO.7 CD and 105.0 UC) cases per 
105 inhabitants. Among 1016 IBD patients (519 CD and 497 UC), females outnumbered males in CD 
(p<0.001), but males were more represented in elderly UC patients (p=0.008). Thus, being a 
male was statistically associated with UC (Relative Risk (RR) 1.25; p=0.013), whereas being a 
female was associated with CD (RR 1.27; p=0.007). Living in an urban zone was associated with 
both CD and UC (RR 1.49; p<0.001, 1.63; p<0,001, respectively). From 1960 to 2005, increases 
in UC and CD prevalences of 2.4% (95%CI, 2.1%-2.8%; p<0.001) and 3.6% (95%CI, 3.1%-4.1%; 
p<0.001) per annum were found in industrialised countries. 
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Francophones de Pathologie digestive in 2006 and 2007. 
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Conclusions: Extrapolating our data to all of Switzerland yields an estimate of 12,000 IBD cases 
for the country, or 1 in 500 inhabitants. Our study gives support to an increase in IBD prevalence 
in Europe. 
© 2007 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved. 
1. Introduction 
Crohn's Disease (CD) and Ulcerative Colitis (UC), the two 
major subtypes of lnflammatory Bowel Diseases (IBD), are 
characterized by chronic inflammation of the bowel, 
immunologically mediated and probably resulting of a loss 
of tolerance to the endogenous enteric flora, inducing an 
inappropriate activation of the mucosal immune system. 1 
Although the cause remains unclear, extrinsic environmental 
factors play probably an important role in their pathogen-
esis. They include smoking, NSAIDS4 and oral contraceptives 
consumption5 and are associated with a high socio-econom-
ical status. 6, 7 Appendectomy (protective for UC but not for 
CD)8 or the occurrence of a viral gastrointestinal infection 
seems to also play a role in the development of these 
diseases. lt has been long known that individuals are 
genetically predisposed to develop such diseases (family 
clustering, twins studies, ethnie groups with high preva-
lence). 9- 11 Genes associated with a disease predisposition 
have been reported for CD. 
The highest IBD prevalence has always been reported in 
North America and Europe and few other countries such as 
Israel, Australia and South Africa. The prevalence tends to 
stabilise in North America, as suggested by the data from the 
Maya Clinic in Rochester, Minnesota (USA). Regarding 
incidence, arise has been observed since the second half of 
the 20th century for bath diseases, but the incidence appears 
now to decrease for UC white it is still slightly increasing for 
CD, as mainly reported in Europe. Currently, although 
data are sparse, the IBD incidence seems to increase in 
Asia21 ' 22 and Central and South America23 25 with a possible 
association to their industrialisation and changes in life-
style. ln many populations studied, an urban-rural gradi-
ent?, 15 ,27,zs has been observed as well as, in Europe and USA, 
a North-South gradient. 29 ,30 However, epidemiological data 
collected during the nineties were influenced by many 
factors: among them the varying organisations of the health 
care system, the facilities available (endoscopy, radiology) 
which differ widely from one country to another, as well as 
the health awareness of the population. 
No study has previously evaluated the IBD prevalence in 
Switzerland. The sole epidemiological data available in 
Switzerland stemmed from a prospective study of 110 cases 
of CD, identified in the Basle area over a 10-year period from 
1960-1969, and based only on incident cases. At this time, 
no endoscopie and histological-based confirmation of the 
diagnosis was available. The incidence rate increased over 
time from 1.6 to 2.6 per 100,000 inhabitants. A prospective 
9-year follow-up of these patients showed frequent relapses 
with or without intestinal resection and an increased risk of 
cancer. 
Switzerland has the advantages of its smalt geographic 
size and central location in Europe (less influence of the 
European North-South and East- West gradients29 ). lt is the 
fifth country in Europe regarding incarne per capita. 
The insurance system offers ail inhabitants equal access 
(obligatory basic insurance) to health care with a high 
medical density (4.6 medical doctor per 1000 inhabitants; 
4th country in the world). As health care reimbursement 
requires that patients seek care in their canton of residence, 
identification of ail patients belonging to our population is 
largely ensured. 
The aim of this study was to estimate for the first time 
a population-based prevalence for IBD in Switzerland and 
to identify factors associated with this disease. This paper 
presents the results of our retrospective and prospective 
identification of UC and CD cases in the Canton of Vaud 
(9% of the Swiss population), obtained by cross matching 
different sources (paper and computerized) of medical 
information. The above-described characteristics of Swit-
zerland and its health care system make our observations 
well suited to represent the current situation in Western 
Europe. 
2. Methods 
2.1. Setting 
Based on the 2000 Swiss census, the Canton of Vaud has a 
population whose age and sex distribution reflects that of 
Switzerland. This population has remained stable, as global 
migration movement was less than 1 % of the whole Canton 
population in 2004. 37 Seventy-five percent of the people 
reside in urban zones, which are made of 5 agglomerations 
around main cities of the Canton. Agglomerations are defined 
by the number of inhabitants, active population, economical 
structure and communication accesses. 18 
2.2. Case ascertainment 
The diagnosis of IBD was based on the criteria established 
by Lennard-Jones. 39•4° Cases (~ 20 years old) were identi-
fied during a 18-month survey (1st July 2003-31st Decem-
ber 2004), based on lists pre-established by all 
gastroenterologists of the Canton of Vaud that included all 
patients seen during the preceding 12 months. Their lists 
were matched against lists of biopsy specimens provided by 
ail pathology centers and further cross-matched with the 
results of a search by an investigator (PJ) in the gastro-
enterologist's computerized correspondence, using the 
keywords "Crohn", "colitis" and usual abbreviations to 
name these diseases. Ali gastroenterologists' offices used 
Microsoft® office Ward software for at least 5 years, a 
system that permits keyword search in ail free text 
documents. When the diagnosis remained unclear or in 
case of mismatch, clinicat, radiological, endoscopie and 
histological findings were reviewed in the medical charts, 
during visits at the gastroenterologists' offices. Difficult 
cases were further discussed with the gastroenterologist in 
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Table 1 Age and sex-adjusted prevalence rates of UC and CD36 
Age (yr) N Prevalence N Prevalence N Prevalence 
(IBD) rate a (UC) ratea (CD) ratea 
Males 
20-29 71 179.2 28 70.7 43 108.5 
30-39 114 231.6 56 113.8 58 117.8 
40-49 119 240.2 76 153.4 43 86.8 
50-59 76 189.0 39 97.0 37 92.0 
60-69 57 198.9 36 125.6 21 73.3 
70-79 33 179.1 20 108.6 13 70.6 
>= 80 14 146.6 10 104.7 4 41.9 
Total 484 205.8 265 112.7 219 93.1 
Adjusted b 5771 205.8 (200.5-211.2] 3149 113.0 (109.1-117.0] 2622 92.8 (89.3-96.5] 
Females 
20-29 52 131.4 17 43.0 35 88.5 
30-39 129 251.5 62 120.9 67 130.6 
40---49 130 263.2 57 115.4 73 147.8 
50-59 93 219.1 40 94.3 53 124.9 
60-69 65 202.8 27 84.3 38 118.6 
70-79 36 143.9 15 60.0 21 84.0 
>= 80 27 140.4 14 72.8 13 67.6 
Total 532 205.4 232 89.6 300 115.8 
Adjustedb 6206 205.3 (200.2-210.5] 2721 89.5 (86.1-92. 9] 3486 115.9 (112.0-119.8] 
Total 
20-29 123 155.3 45 56.8 78 98.5 
30-39 243 241.8 118 117.4 125 124.4 
40-49 249 251.7 133 134.4 116 117.3 
50-59 169 204.5 79 95.6 90 108.9 
60-69 122 201.0 63 103.8 59 97.2 
70-79 69 158.8 35 80.6 34 78.3 
>= 80 41 142.5 24 83.4 17 59.1 
Total 1016 205.6 497 100.6 519 105.0 
Adjusted b 11, 977 205.7 [202.0-209.4] 5870 100.7 (98.2-103.4] 6108 105.0 (102.3-107.7] 
a Crude rate (cases per 100,000 person years). 
b Male and female rates are age adjusted to Swiss population, 2004 [95% confidence interval (Cl)]. 
charge of the patients or with a senior IBD specialist (PM). 
Patients with a final diagnosis of indeterminate colitis or 
suspected of having another aetiology (i.e. ischemic or 
pseudomembranous colitis) and cases of acute colitis (less 
than 6 week-long) were not included in the study. Lists of 
patients confirmed by the investigators were sent back to 
the treating gastroenterologists for final agreement. The 
information collected for each patient included: diagnosis, 
age, sex and postal address. Records were anonymized when 
entered in the computerized database. 
2.3. Statistical analysis 
To calculate prevalence, the adult population of the canton 
of Vaud over 20 years of age was considered at risk for IBD. 
The prevalence rates were calculated by age groups and 
gender, based on official vital statistics for the Canton of 
Vaud in 2004. Rates were then age and sex adjusted to the 
Swiss population and confidence intervals were computed. 
Socio-demographic factors that could be associated with 
prevalence of IBD included age, sex, geographic location 
(urban versus rural), and density of population. The effects 
of these factors were assessed separately for UC and CD, 
using stepwise multivariable Poisson regression model. 
Relative Risk (RR) were calculated for factors that signifi-
cantly (p<0.05) influenced the prevalence of IBD. 
2.4. Literature review/international comparison 
To compare our data with previous studies and to better 
characterize the change in prevalence in industrialised 
countries during the last four decades, an OVID search was 
performed on the databases MEDLINE (1966-2007), OLD 
MEDLINE (1950-1966), Cochrane Library 2007 (Cochrane 
DSR, ACP Journal Club, DARE, and CCTR), CINAHL with the 
MESH word Crohn's Disease/ep (subheadings Epidemiology) 
OR Colitis, Ulcerative/ep (subheadings Epidemiology) and 
epidemiology OR prevalence OR incidence as keywords. 
Further references were extracted from bibliographies of 
review articles in the field and from the referenced 
articles hereby. We selected studies performed in countries 
of high prevalence such as North America, Scandinavia and 
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Figure 1 UC and CD prevalence by age groups and gender. 
the UK, and in countries with an interesting geographical 
location for Switzerland (North, South and East Europe). 
Values of prevalence for CD and UC were extracted and 
classified for comparison according to the time period, 
geographical location, population size and type of study. 
Estimated annual percent change in CD and UC prevalences 
were assessed, assuming a linear increase on the logarith-
mic scale. 
Figure 2 Geographic distribution of IBD diagnosis in the canton of Vaud, Switzerland. 
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Table 2 Multivariate analyses of socio-demographic factors associated with IBD 
Variable Ulcerative Colitis 
RR 95% Cl 
Males Reference 
Females 0.80 0.67-0.95 
20-29 yr 0.48 0.34-0.68 
30-39 yr Reference 
40-49 yr 1.15 0.90-1.47 
50-59 yr 0.82 0.62-1.09 
60-69 yr 0.89 0.66-1.21 
70-79 yr 0.70 0.48-1.03 
>=80yr 0.74 0.48-1.15 
Rural zone Reference 
Urban zone 1.63 1.29-2.07 
2.5. Ethical considerations 
The study was approved by the ethical committee of the 
University of Lausanne, Switzerland. 
3. Results 
3. 1. Prevalence rates 
Among the Canton of Vaud adult population (494,202 inhabi-
tants), we identified 1016casesof IBD, 519 (51%) cases of Crohn's 
Disease (CD) and 497 (49%) cases of Ulcerative Colitis (UC). The 
sex repartition was 532 women (52%) and 484 men (48%). 
The crude prevalence rate was 205.6 IBD cases per 105 
inhabitants, corresponding to 100.6 Crohn's Disease cases and 
105.0 Ulcerative Colitis cases per 105 inhabitants. Age and sex-
adjusted prevalence for IBD, CD and UC is given in 
Ulcerative Colitis 
2 -----------------------
1.5 - - - - - - - -
0.5 - - - - - - - - - - - - - - -
0+---l--+--+--l~+-+--+--+--l~l--+---l--1 
Crohn's Disease 
p-value RR 95% Cl p-value 
Reference 
0.013 1.27 1.07-1.51 0.007 
<0.001 0.79 0.60-1.05 0.102 
Reference 
0.270 0.95 0.74-1.22 0.691 
0.174 0.88 0.67-1.15 0.351 
0.463 0.78 0.57-1.06 0.117 
0.067 0.62 0.43-0.91 0.015 
0.185 0.46 0.28-0.76 0.003 
Reference 
<0.001 1.49 1.19-1.87 <0.001 
3.2. Age stratification 
The stratification by age groups ) showed that the 
highest prevalence rate for CD was found between the ages 
of 30 and 39 years old (124.4 cases per 105 persans), and for 
UC between the ages of 40 and 49 years old (134.4 cases per 
105 persans), followed by a slow decline, more pronounced 
for CD than for UC in the later decades of life. From age 60 
on, the prevalence of UC in males was higher than in females, 
whereas the reverse was observed for CD. 
3.3. Geographical distribution 
The geographical distribution of IBD cases in the Canton of 
Vaud is represented in 2, with the five agglomerations 
mentioned. Eighty-three percent of IBD patients were found in 
urban areas. The highest prevalence was found in the densest 
agglomeration of Lausanne with 242. 9 cases per 105 persans. 
Crohn's Disease 
2 
T 
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Figure 3 Multivariate analyses of socio-demographic factors associated with IBD. 
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Table 3 Prevalence rates (per 100, 000 population) for Crohn's disease (CD) and Ulcerative colitis (UC) 
References Country Year§ CD uc Population (inhab.) 0 Study category 
Juillerat et al. Switzerland 2004 105 101 524,040 PB 
USA+Canada 
Herrington LJ et al. USA 2001 129 191 1,800,000 HMO-B 
Loftus CG et al. USA 2000 162 246 124,000 PB 
Bernstein CN et al. Canada 1994 198.5 169.7 1, 140,000 PB 
Loftus EV et al. USA 1990 144.1 229 106,000 PB 
Kurata JH et al. USA 1988 25.9 652,510 HMO-B 
Pinchbeck BR et al. Canada 1981 44.4 37.2 1,295,360 PB 
Gollop, J. H. et al. USA 1979 90.5 90,600* PB 
Stonnington, CM. et al. USA 1979 212.6 n.a. PB 
Sedlack R.E. et al. USA 1975 105.7 117.7 89,000* PB 
MonkM et al. USA 1963 42 n.a. HB 
United Kingdom 
Lee FI et al. England 1997 47 300,000 HB 
Rubin G. Pet al. England 1994 144.8 243.4 179,496 PB 
Prabert, C. S. et al. England 1989 75.8 128 900,000 PB 
Kyle, J. et al. Scotland 1988 147 67 509,400 HB 
Fellows, IW et al. England 1985 85 215,300 PB 
Jones HW et al. England 1984 70 270,000 HB 
Mayberry JF et al. England 1980 55.5 130,450 HB 
Devlin HB et al. England 1977 35 99 200,000 HB 
Mayberry et al. Wales 1976 40.2 2,731,204 HB 
Miller DS et al. En gland 1972 26.5 464,000 PB 
Kyle, J. et al. Scotland 1969 32.5 442,000 HB 
De Dombal FT et al. England 1968 25 n.a. PB 
Evans et al. England 1960 9 79.9 264,000 PB 
Wright JT. et al. England n.a. 12 n.a. n.a. 
Scandinavia 
Lapidus, A. Sweden 2001 213 1,470,000 PB 
Lindgren, A.et al. Sweden 1990 94 331,500 PB 
Munkholm P. +Langholz E. et al. Denmark 1987 54 161.2 554,533 PB 
Tysk, C. +Lindberg, E et al. Sweden 1987 146 234 164,972 PB 
Haug, K., E. et al. Norway 1985 92 807,000 PB 
Berner, J. et al. Faroe Island 1983 31.8 157.3 44000 PB 
Bjornsson, S. et al. lceland 1979 10.7 122.2 221,854 PB 
Binder, V. et al. Den mark 1978 34 117 500,000 PB 
Hellers G et al. Sweden 1974 54,2 1,490,800* PB 
Bergman, L. et al. Sweden 1973 50 412,000 PB 
Brahme, F. et al. Sweden 1973 75.2 251,431 PB 
Bjornsson, S. et al. lceland 1969 62.6 n.a. PB 
Brahme, F. et al. Sweden 1968 89 n.a. PB 
Bonnevie, O. et al. Denmark 1967 44.1 574,000 PB 
Norlen BJ, et al. Sweden 1967 27 412,000 PB 
North Europe 
Loeffler A. et al. Germany 1986 30.7 922,552 PB 
Daiss, W. et al. Germany 1984 54.6 24.8 1,515,000 PB 
Dirks, E.et al. Germany 1984 27,3 1,600,000 PB 
Shivananda, S. et al. The Netherlands 1983 48 58.4 439,815 PB 
Brandes, J. W. et al. Germany 1972 30.5 48.8 172,215 PB 
South Europe 
Trallori G. et al. ltaly 1992 40 121 540,000 PB 
Alonso P. et al. Spain 1990 13 32 100,000 PB 
Hinojosa, J. et al. [95] Spain 1989 21.4 28.8 55,866 HB 
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Table 3 (continued) 
Ref erences 
South Europe 
Martinez-Salmeron J.F. et al. 
Mate-Jimenez J. et al. 
East Europe 
Gheorghe, C. et al. 
Lakatos L. et al. 
Prikazska M. et al. 
Vucelic, B. et al. 
Bitter J. et al. [102] 
*Calculated values r. 
'Study categories. 
Country 
Spain 
Spain 
Romani a 
Hungary 
Slovakia 
Croatia 
Czech republic 
HMO: based on health maintenance organisation (HMO) registries. 
HB: based on hospital registries. 
PB: population-based. 
n.a.: not assessed. 
There was also a higher prevalence in two other urban areas 
with populations of more than 50,000 inhabitants, whereas in 
agglomerations of less than 50,000 inhabitants, the crude 
prevalence rate was the same as in rural regions (complemen-
tary analysis not shown). 
3.4. Extrapolation to Switzerland 
As the population of the Canton of Vaud is comparable ta the 
general Swiss population, according ta age and sex distribution, 
numbers of patients were extrapolated for the whole country. 36 
Based on our observed values, we estimate that about 12,000 
persans suffer from IBD (6100 from CD and 5900 from UC) in 
Switzerland. 
3.5. Socio-demographic factors associated with 
prevalence 
A multivariable Poisson regression analysis was performed ta 
determine the association between relevant socio-demographic 
factors available for the population of the Canton of Vaud and 
IBD prevalence. Results are shown in and Factors 
OCD 250~ 
"'uc 
s 200 g 
0 
0 
:::; 150 
~ g 
Q) 100 
~ 
a. 50 
Year§ CD uc Population (inhab.) ' Study category 
1988 9 21 >20,000 HB 
1988 19.8 43.4 334,000 PB 
2003 1.5 2.4 21,698, 181 HB 
2001 52.9 142.6 376,000 PB 
1994 6.8 n.a. PB 
1989 8.3 21.4 1, 175,500 PB 
1979 12 n.a. PB 
associated with UC were being a male (Relative Risk (RR) 1.25; 
95% confidence interval (Cl), 1.05-1.49; p=0.013) and living in 
an urban zone (RR 1.63; 95% Cl, 1.29-2.07; p<0.001 ), whereas 
being a female (RR 1.27; 95% Cl, 1.07-1.51; p=0.007) and 
living in an urban zone (RR 1.49; 95% Cl, 1.19-1.87; p<0.001) 
were associated with CD. The association with age was 
different for UC and CD. The RR for UC doubled for people 
between 30-39 years of age as compared ta those ten years 
younger (p<0.001) and peaked in the 40-49 age group. The 
prevalence of CD was maximal in the 30-39 year old age group, 
then diminished gradually with age. From the age of 70 years, 
the prevalence was significantly lower than between 30 and 
39 years of age. 
3.6. Medical density, health consumption and 
diagnosis delay 
A univariate analysis showed that the medical density was ta 
some extent related ta the number of IBD diagnoses. From 
two general practitioners per thousand inhabitants or one 
gastrointestinal specialist per district, the IBD prevalence 
did not further increase with denser medical coverage. 
0 
1965 1970 1975 1980 1985 1990 1995 2000 2005 
Figure 4 Time trends in CD and UC prevalences in selected population-based studies. 
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Figure 5 CD and UC prevalence according to population size (log scale) in selected population-based studies. 
3.7. Literature review 
Six hundred seventy articles were identified from 1966 till 
June 2007, then imported to a references database (End-
note®) for a manual selection. However, most epidemiological 
articles that were retained were issued from a manual search 
in the bibliography of selected articles. During this process, 
articles were excluded if they were only considering incidence 
or other epidemiological themes that differ from prevalence. 
gives details on prevalence data, time period, type of 
study and population size of 57 epidemiological studies on IBD 
prevalence in Europe and North America. The prevalences 
found in these population-based or hospital-based studies 
ranged from 2 to 213 CD patients per 105 inhabitants and from 2 
to 246 UC patients per 105 inhabitants. Most studies directly 
used heath maintenance organisation (HMO) registries, hospi-
tal registrîes or medîcal records to calculate the prevalence. 
The last study that analyzed retrospectively medîcal records 
was made in 1997.41 Other studies were based on the 
identification of incident IBD cases, with durations that were 
considered suffîcîent to extrapolate prevalence values. The 
most recent updated study of this category cornes from the 
Olmsted County in 2006. 17 Plotting data from population-
based studies simîlar to our study (USA, UK, Scandinavia, North 
and South Europe) over time, we observed between 1960 and 
2005, an annual increase of IBD prevalence of 2.4% (95%CI, 
2.1%-2.8%) and 3.6% (95%CI, 3.1%-4.1%) for UC and CD, 
respectively 4). This increase was statistically significant 
in bath cases. Prevalence for Switzerland was in line with the 
international trend for CD, but was lower for UC. A repre-
sentation of the prevalence values according to population size 
showed little influence of the size of the population studied on 
the prevalence rates, whîch were globally higher for UC than 
CD 5). 
4. Discussion 
This first population-based study undertaken in Switzerland 
enables the identification of more than one thousand IBD 
patients at the end of 2004 in the Canton of Vaud, with an 
equal distribution between UC and CD cases. The prevalence 
rates were for UC 105.0 and for CD 100. 7 patients per 105 
inhabitants. If our results are extrapolated to the whole 
country, more than twelve thousand people suffer from IBD 
in Switzerland. 
There were several strengths in our study. Firstly, the pop-
ulation size (half a million inhabitants), its stabîlîty and a good 
and uniform access to health care. lndeed, we observed that 
patients had the same likelihood to be diagnosed with IBD in 
each district of our study area. Secondly, geographîc location 
of Switzerland in the middle of Europe makes our country 
"representative" for epidemiological studies without being 
affected by a North-South or West-East gradient. 
The main limitation of this study was the confinement to 
adult individuals (over 20 years old) followed by gastroenter-
ologists. Notwithstanding, our independent sources of data 
(gastroenterologists, pathologists, hospitals) presented a 
suffîcîent overlap to be confident that our study comprehen-
sively covered the population under scrutîny. This is supported 
by a recent study that showed the central role of gastroenter-
ologists in the management of IBD patients in Swîtzerland. 
The age-adjusted prevalence of IBD in our study was com-
parable to the rates reported in Europe and North America 
over the last twenty years. Our values, when compared with 
prevalences in other population-based studies were lower than 
the most recent values found in North America, in United 
Kingdom and in Scandinavia, but two to fivefold larger than 
rates from South and East Europe 3). They were also 
doubled in comparison with data from population-based stud-
ies made between the end of the eighties and the beginning of 
the nineties in the closest geographical countries (ltaly, 
German y and the Netherlands ). This might suggest a persistent 
annual increase of prevalence of both diseases, which seems to 
be more important for CD than for UC over the last 45 years. 
However it is not possible to know if the prevalence increase 
remains actually at the same level as calculated here in 
the previous decades, but further analysis did not identify 
any plateau phase as described for the incidence in some 
countries. ' 3 ~w,43 
We observed a higher prevalence of CD than UC, as was 
also reported in two neighboring countries, Germany27 and, 
indirectly, France ("Franco-Belge exception"). 44 48 We 
found that the prevalence of CD, but not of UC, was sub-
stantially higher among females (p<0.001 ), in keeping with 
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previous studies. 13,49 - 51 We observed a slight male predomi-
nance of UC over age 50 2) that confirmed longstanding 
observations from the Maya clinic (Olmsted County, Minne-
sota USA). 15 Our cohort has a remarkably low proportion of 
CD patients over 60 years old. We believe that it could be in 
part due to an increased mortality in CD patients, in par-
ticular with an age above 40 years at diagnosis, as described 
in a recent population-based cohort. 
ln our cohort, living in an urban area was an important and 
independent socio-demographic factor associated with IBD. 
Many previous studies described an urban-rural gradi-
ent. 7· 15·27·28 An analysis of smoking habit in IBD patients 
showed no difference between rural and urban areas (own 
data, not published). There was also no significant difference 
with the general population, but data are lacking to clarify if 
tobacco consumption is an environmental factor associated 
with the population density. Other environmental factors 
need to be further studied to determine their contribution to 
the variation in prevalences which is only partly explains by 
the above mentioned factors. 
ln conclusion, our study estimates that 0.2% of the Swiss 
adult population suffers from IBD. On the basis of these 
values and the perception of an increase of bath UC and CD 
prevalences supported by our detailed analysis of published 
data, we emphasize the importance to start up prospective 
cohorts to evaluate direct and indirect costs of IBD for the 
society. 
Acknowledgement 
We thank all the gastroenterologists who participated in this 
study: Bretholz A, Delarive J, Dorta G, Frei A, Gallot-Lavallée 
S, Gonvers JJ, Gross M, Guyot J, Hess J, Nicolet T, Schacher G, 
Schnegg JF, Séchaud R, Stadler P, Thorens J, Viani F, Voirol M, 
Vouillamoz D, Wiesel P. This study was supported by the 
Swiss National Fund for Scientific Research (Grant no. 3347C0-
108792/ 1 ). 
References 
1. Hanauer SB. lnflammatory bowel disease. N Engl J Med 1996; 334: 
841-8. 
2. Podolsky DK. lnflammatory bowel disease. N EnglJ Med2002;347: 
417-29. 
3. Cosnes J, Beaugerie L, Carbonnel F, et al. Smoking cessation 
and the course of Crohn's disease: an intervention study. Gas-
troenterology 2001; 120: 1093-9. 
4. Evans JM. Non-steroidal anti-inflammatory drugs are associated 
with emergency admission to hospital for cotitis due to inflam-
matory bowel disease. Gastroentero/ogy 1997;40:619-22. 
5. Garcia Rodriguez LA, Gonzalez-Perez A, Johansson S, et al. Risk 
factors for inflammatory bowel disease in the general popula-
tion. Aliment Pharmacol Ther 2005;22:309-15. 
6. Alic M. Socioeconomics of Crohn's disease: a review of 
epidemiology and an etiological hypothesis. Am J Gastroentero/ 
2000;95: 324-6. 
7. Blanchard JF, Bernstein CN, Wajda A, et al. Small-area variations 
and sociodemographic correlates for the incidence of Crohn's 
disease and ulcerative colitis. Am J Epidemiol 2001; 154: 
328-35. 
8. Andersson RE, Olaison G, Tysk C, et al. Appendectomy and 
protection against ulcerative colitis. N Engl J Med 2001 ;344: 
808-14. 
9. Tysk C, Lindberg E, Jarnerot G, et al. Ulcerative-colitis and 
Crohns-disease in an unselected population of monozygotic and 
dizygotic twins - a study of heritability and the influence of 
smoking. Gut 1988;29:990-6. 
10. Roth M, Petersen G, McElree C, et al. Geographic origins of 
Jewish patients with inflammatory bowel disease. Gastroenter-
ology 1989;97:900-4. 
11. Orholm M, Munkholm P, Langholz E, et al. Familial occurrence 
of inflammatory bowel-disease. N Engl J Med 1991 ;324:84-8. 
12. Ogura Y, Bonen DK, lnohara N, et al. A frameshift mutation in 
NOD2 associated with susceptibility to Crohn's disease. Nature 
2001;411:603-6. 
13. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 
leucine-rich repeat variants with susceptibility to Crohn's 
disease. Nature 2001 ;411 :599-603. 
14. Loftus E, Silverstein M, Sandborn W, et al. Crohn's disease in 
Olmsted County, Minnesota, 1940-1993: incidence, preva-
lence, and survival. Gastroenterology 1998; 114:1161-8. 
15. Loftus Jr EV, Silverstein MD, Sandborn WJ, et al. Ulcerative 
colitis in Olmsted County, Minnesota, 1940-1993: incidence, 
prevalence, and survival. Gut 2000;46:336-43. 
16. Loftus Jr EV, Sandborn WJ. Epidemiology of inflammatory 
bowel disease. Gastroentero/ Clin North Am 2002;31 :1-20. 
17. Loftus CG, Loftus Jr EV, Harmsen WS, et al. Update on the 
incidence and prevalence of Crohn's disease and ulcerative colitis 
in Olmsted County, Minnesota, 1940-2000. lnflamm Bowel Dis 
2007; 13:254-61. 
18. Russel MG, Stockbrugger RW. Epidemiology of inflammatory 
bowel disease: an update. Scand J Gastroenterol 1996; 31: 
417-27. 
19. Fonager K, Sorensen H, Olsen J. Change in incidence of Crohn's 
disease and ulcerative colitis in Denmark. A study based on the 
National Registry of Patients, 1981-1992. /ntJ Epidemiol 1997; 26: 
1003-8. 
20. Binder V. Epidemiology of IBD during the twentieth century: 
an integrated view. Best Pract Res Clin Anaesthesiol 2004;18: 
463-79. 
21. Yang SK, Loftus Jr EV, Sandborn WJ. Epidemiology of inflam-
matory bowel disease in Asia. lnflamm Bowel Dis 2001 ;7: 
260-70. 
22. Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of 
Crohn's disease in the Chinese population. lnflamm Bowe/ Dis 
2004; 10:646-51. 
23. Linares de la Cal JA, Canton C, Pajares JM, et al. lnflammatory 
bowel disease in Argentina and Panama (1987-1993). Eur J 
Gastroenterol Hepatol 1997;9:1129. 
24. Souza MH, Troncon LE, Rodrigues CM, et al. Trends in the 
occurrence (1980-1999) and clinicat features of Crohn's 
disease and ulcerative colitis in a university hospital in 
southeastern Brazil. Arq Gastroenterol 2002;39:98-105. 
25. Appleyard CB, Hernandez G, Rios-Bedoya CF. Basic epidemiol-
ogy of inflammatory bowel disease in Puerto Rico. lnf/amm 
Bowet Dis 2004;10:106-11. 
26. Hanauer SB. lnflammatory bowel disease: epidemiology, patho-
genesis, and therapeutic opportunities. lnflamm Bowel Dis 
2006;12: 53-9. 
27. Daiss W, Scheurlen M, Malchow H. Epidemiology of inflamma-
tory bowel-disease in the county of Tubingen (West-Germany). 
Scand J Gastroentero/ 1989;24:39-43. 
28. Mate-jimenez J, Munoz S, Vicent D, et al. Incidence and 
prevalence of ulcerative-colitis and Crohns-disease in urban 
and rural-areas of Spain from 1981 to 1988. J Clin Gastroenterol 
1994; 18:27-31. 
29. Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of 
inflammatory bowel disease across Europe: is there a differ-
ence between north and south? Results of the European 
Collaborative Study on lnflammatory Bowel Disease (EC-IBD). 
Gut 1996;39: 690-7. 
Please cite this article as: Juillerat P, et al, Prevatence of fnflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-
based cohort study, J Crohn's Colitis (2007), 
10 
30. Loftus EV. Clinical epidemiology of inflammatory bowel 
disease: incidence, prevalence, and environmental influences. 
Gastroenterotogy 2004; 126: 1504-17. 
31. Moum B, Ekbom A. Epidemiology of inflammatory bowel disease -
methodological considerations. Dig Uver Dis 2002;34:364-9. 
32. Fahrlander H, Baerlocher C. Clinicat features and epidemiolo-
gical data on Crohn's disease in the Basle area. Scand J 
Gastroenterot 1971 ;6:657-62. 
33. Fahrlander H, Shalev E. Die Enterocolitis regionalis Crohn. Eine 
Verlaufs- und Vergleichsstudie anhand von 182 Patienten. 
Dtsch Med Wochenschr 1974;99:2207-14. 
34. Branger K, Gazareth P, Modetta C, et al. Revenus et bien être, 
niveau de vie et avantage sociaux en Suisse. Neuchâtel: Office 
fédérale de la statistique; 2002. 
35. Examens de l'OCDE des systèmes de santé. Suisse; 2006. 
36. Annuaire statistique de la Suisse 2005. Zürich: Office fédéral de 
la Statistique; 2005. 
37. Annuaire statistique du Canton de Vaud. Service cantonal de 
recherche et d'information statistiques (SCRIS); 2005. www. 
scris. vd.ch. 
38. Da Cunha A, Bath J. Recensement fédéral de la population 
2000: Métropolisation, villes et agglomérations Structures et 
dynamiques socio-démographiques des espaces urbains; 2004. 
39. Lennard-Jones JE. Regional enteritis (Crohn's disease): defini-
tion and diagnosis. Skandia International Symposia. Regional 
Enteritis. Nordiska Bolchandelns Forlag; 1970. p. 108-9. 
40. Lennard-Jones JE. Classification of inflammatory bowel-dis-
ease. Scand J Gastroenterot 1989;24:2-6. 
41. Rubin GP, Hungin AP, Kelly PJ, et al. lnflammatory bowel 
disease: epidemiology and management in an English general 
practice population. Aliment Pharmacot Ther 2000; 14: 1553-9. 
42. Beltinger J, Froehlich F, Mitglieder von IC. Patients with inflam-
matory bowel disease in specialist gastroenterology practice: a 
prospective survey. Schweiz Rundsch Med Prax 2005;94:459-65. 
43. Farrokhyar F, Swarbrick ET, lrvine EJ. A critical review of 
epidemiological studies in inflammatory bowel disease. Scand 
J Gastroenterot 2001; 36:2-15. 
44. Gower-Rousseau C, Salomez JL, Dupas JL, et al. Incidence of 
inflammatory bowel-disease in Northern France (1988-1990). 
Gut 1994;35:1433-8. 
45. Latour P, Belaiche J, Louis E, et al. Incidence of inflammatory 
bowel disease in the province of Liege (Belgium). La Societe de 
Gastroenterologie Liegeoise. Acta Gastroenterot Betg 1996;59: 
3-6. 
46. Pagenault M, Tron 1, Alexandre JL, et al. Incidence of inflam-
matory bowel diseases in Bretagne (1994-1995). ABERMAD. 
Association Bertonne d'Etude et de Recherche des Maladies de 
['Appareil Digesif. Gastroenterot Clin Biot 1997;21 :483-90. 
47. Gower-Rousseau C, Grandbastien B, Colombel JF, et al. Incidences 
des maladies inflammatoires chroniques de l'intestin, en France: 
le tableau s'enrichit. Gastroenterot Clin Biot 1997;21 :481-2. 
48. Molinie F, Gower-Rousseau C, Yzet T, et al. Opposite evolution 
in incidence of Crohn's disease and ulcerative colitis in 
Northern France (1988-1999). Gut 2004;53:843-8. 
49. Calkins BM, Mendeloff Al. Epidemiology of inflammatory bowel 
disease. Epidemiot Rev 1986;8:60-91. 
50. Bernstein C, Blanchard J, Rawsthorne P, et al. Epidemiology of 
Crohn's disease and ulcerative colitis in a central Canadian 
province: a population-based study. Am J Epidemiot 1999; 149: 
916-24. 
51. Loftus Jr EV, Schoenfeld P, Sandborn WJ. The epidemiology and 
natural history of Crohn's disease in population-based patient 
cohorts from North America: a systematic review. Aliment 
Pharmacot Ther 2002; 16:51-60. 
52. Wolters FL, Russel MG, Sijbrandij J, et al. Crohn's disease: 
increased mortality 10 years after diagnosis in a Europe-wide 
population based cohort. Gut 2006;55:510-8. 
P. Juillerat et al. 
53. Herrinton LJ, Liu L, Lafata JE, et al. Estimation of the period 
prevalence of inflammatory bowel disease among nine health 
plans using computerized diagnoses and outpatient pharmacy 
dispensings. lnftamm Bowet Dis 2007; 13:451-61. 
54. Kurata JH, Kantorfish S, Frankl H, et al. Crohns-disease among 
ethnic-groups in a large health maintenance organization. 
Gastroenterotogy 1992; 102: 1940-8. 
55. Pinchbeck BR, Kirdeikis J, Thomson ABR. lnflammatory bowel-
disease in Northern Alberta - an epidemiologic-study. J Clin 
Gastroenterot 1988; 10:505-15. 
56. Gollop JH, Phillips SF, Mel ton LJ, et al. Epidemiologic aspects of 
Crohns-disease - a population based study in Olmsted County, 
Minnesota, 1943-1982. Gut 1988;29:49-56. 
57. Stonnington CM, Phillips SF, Melton LJ, et al. Chronic 
ulcerative-colitis - incidence and prevalence in a community. 
Gut 1987;28:402-9. 
58. Sedlack RE, Whisnant J, Elveback LR, et al. Incidence of Crohn's 
disease in Olmsted County, Minnesota, 1935-1975. Am J Epidemiot 
1980; 112:759-63. 
59. MonkM, Mendeloff Al, Siegel Cl, et al. An epidemiological study 
of ulcerative colitis and regional enteritis among adults in 
Baltimore. 1. Hospital incidence and prevalence, 1960 to 1963. 
Gastroenterotogy 1968;54:822-4 [Suppl]. 
60. Lee FI, Castello FT. Crohns-disease in Blackpool - incidence 
and prevalence 1968-80. Gut 1985;26:274-8. 
61. Prabert CSJ, Jayanthi V, Hughes AO, et al. Prevalence and 
family risk of ulcerative-colitis and Crohns-disease - an 
epidemiologic-study among Europeans and South Asians in 
Leicestershire. Gut 1993;34:1547-51. 
62. Kyle J. Crohns-disease in the Northeastern and Northern Isles 
of Scotland - an epidemiologic review. Gastroenterotogy 
1992; 103:392-9. 
63. Fellows IW, Freeman JG, Holmes GK. Crohn's disease in the city 
of Derby, 1951-85. Gut 1990;31:1262-5. 
64. Jones HW, Grogono J, Hoare AM. An audit of ulcerative-colitis 
in a District General-Hospital. Gut 1985;26:1123-1123. 
65. Mayberry JF, Dew MJ, Morris JS, et al. An audit of Crohn's disease 
in a defined population. J R Coll Physicians Lond 1983;17: 
196-8. 
66. Devlin HB, Datta D, Dellipiani AW. The incidence and prevalence 
of inflammatory bowel disease in North Tees Health District. 
Wortd J Surg 1980;4: 183-93. 
67. Mayberry JF, Rhodes J, Newcombe RG. Crohn's disease in 
Wales, 1967-1976; an epidemiological survey based on hospital 
admissions. Postgrad Med J 1980;56:336-41. 
68. Miller DS, Keighley AC, Langman MJ. Changing patterns in 
epidemiology of Crohn's disease. Lancet 1974;2:691-3. 
69. Kyle J. An epidemiological study of Crohn's disease in Northeast 
Scotland. Gastroenterotogy 1971 ;61 :826-33. 
70. De Dombal FT. Epidemiology and natural history of Crohn's 
disease. Proc R Soc Med 1971 ;64:161. 
71. Evans JG, Acheson ED. An epidemiological study of ulcerative 
colitis and regional enteritis in Oxford Area. Gut 1965;6:311-24. 
72. Wright J. The prevalence of Crohn's disease in an East London 
borough. Fourth World Congress of gastroenterology Advance 
Abstracts; 1970. p. A 389. 
73. Lapidus A. Crohn's disease in Stockholm County during 1990-
2001: an epidemiological update. Wortd J Gastroenterot 
2006; 12:75-81. 
74. Lindgren A, Wallerstedt S, Olsson R. Prevalence of Crohn's 
disease and simultaneous occurrence of extraintestinal com-
plications and cancer. An epidemiologic study in adults. Scand 
J Gastroenterot 1996;31 :74-8. 
75. Langholz E, Munkholm P, Nielsen OH, et al. Incidence and 
prevalence of ulcerative-colitis in Copenhagen County from 
1962 to 1987. Scand J Gastroenterot 1991 ;26:1247-56. 
76. Munkholm P, Langholz E, Nielsen OH, et al. Incidence and 
prevalence of Crohns-disease in the County of Copenhagen, 
Please cite this article as: Juitlerat P, et al, Prevalence of lnflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-
based cohort study, J Crohn's Colitis (2007), 
Prevalence of lnflammatory Bowel Disease in the Canton of Vaud (Switzerland) 11 
1962-87 - a sixfold increase in incidence. Scand J Gastroenterol 
1992;27:609-14. 
77. Tysk C, Jarnerot G. Ulcerative proctocolitis in Orebro, Sweden. 
A retrospective epidemiologic study, 1963-1987. Scand J 
Gastroenterol 1992;27:945-50. 
78. Lindberg E, Jornerot G. The incidence of Crohn's disease is not 
decreasing in Sweden. Scand J Gastroenterol 1991 ;26:495-500. 
79. Haug K, Schrumpf E, Barstad S, et al. Epidemiology of 
ulcerative-colitis in Western Norway. Scand J Gastroenterol 
1988;23:517-22. 
80. Berner J, Kiaer T. Ulcerative colitis and Crohn's disease on the 
Faroe Islands 1964-83. A retrospective epidemiological survey. 
Scand J Gastroenterol 1986; 21: 188-92. 
81. Bjornsson S, Thorgeirsson T. Colitis ulcerosa i Island epidemio-
logisk undersokning 1950-1979. Nord Med 1983;98:298-301. 
82. Binder V, Bath H, Hansen PK, et al. Incidence and prevalence of 
ulcerative-colitis and Crohns-disease in the county of Copen-
hagen, 1962 ta 1978. Gastroentero/ogy 1982;83:563-8. 
83. Hellers G. Crohn's disease in Stockholm county 1955-1974. A 
study of epidemiology, results of surgical treatment and long-
term prognosis. Acta Chir Scand Suppl 1979;490:1-84. 
84. Bergman L, Krause U. The incidence of Crohn's disease in 
central Sweden. Scand J Gastroenterol 1975; 10:725-9. 
85. Brahme F, Lindstrom C, Wenckert A. Crohns-Disease in a 
defined population - epidemiological study of incidence, 
prevalence, mortality, and secular trends in city of Malmo, 
Sweden. Gastroenterology 1975;69:342-51. 
86. Bonnevie 0, Riis P, Anthonisen P. An epidemiological study of 
ulcerative colitis in Copenhagen County. Scand J Gastroentero/ 
1968;3:432-8. 
87. Norlen BJ, Krause U, Bergman L. An epidemiological study of 
Crohn's disease. Scand J Gastroentero/ 1970;5:385-90. 
88, Loffler A, Glados M. Data on the epidemiology of Crohn disease 
in the city of Cologne. Med Klin 1993;88:516-9. 
89. Dirks E, Forster S, Thom M, et al. Prospektive Untersuchung von 
lnzidenz und Pravalenz der Colitis ulcerosa in einer Gross-
stadtbevOlkerung in Deutschland (Westliches Ruhrgebiet). Z 
Gastroentero/ 1994;32:332-7. 
90. Shivananda S, Pena AS, Nap M, et al. Epidemiology of Crohns-
disease in Regio Leiden, the Netherlands - a population study 
from 1979 ta 1983. Gastroenterology 1987;93:966-74. 
91. Shivananda S, Pena AS, Mayberry JF, et al. Epidemiology of 
proctocolitis in the region of Leiden, The Netherlands. A 
population study from 1979 to 1983. Scand J Gastroenterol 
1987;22:993-1002. 
92. Brandes JW, Lorenzmeyer H. Epidemiological aspects of 
enterocolitis regionalis Crohn and colitis ulcerosa in Marburg 
Lahn (Frg) from 1962 ta 1975. Z Gastroenterol 1983;21 :69-78. 
93. Trallori G, Palli D, Saieva C, et al. A population-based study of 
inflammatory bowel disease in Florence over 15 years (1978-
92). Scand J Gastroenterol 1996;31 :892-9. 
94. Alonso P, Ulla M, Soriano M, et al. lnflammatory bowel-disease 
in Soria Province - retrospective clinical and epidemiologic-
study 1981-1990. Rev Esp Enferm Dig 1992;82:87-91. 
95. Hinojosa J, Primo J, Lledo S, et al. Incidence of inflammatory 
bowel-disease in Sagunto. Rev Esp Enferm Dig 1990;78:283-7. 
96. Martinez salmeron JF, Rodrigo M, Deteresa J, et al. Epidemiol-
ogy of inflammatory bowel-disease in the Province of Granada, 
Spain - a retrospective study from 1979 ta 1988. Gut 1993;34: 
1207-9. 
97. Gheorghe C, Pascu 0, Gheorghe L, et al. Epidemiology of 
inflammatory bowel disease in adults who refer ta gastro-
enterology care in Remania: a multicentre study. Eur J 
Gastroenterol Hepato/ 2004; 16:1153-9. 
98. Lakatos L, Mester G, Erdelyi Z, et al. Striking elevation in 
incidence and prevalence of inflammatory bowel disease in a 
province of western Hungary between 1977-2001. World J 
Gastroenterol 2004; 10:404-9. 
99. Prikazska M, Letkovicova M, Matejickova V. Crohns disease in 
Slovakia: Prevalence, socioeconomic and psychological analy-
sis. EurJ Epldemiol 1998;14:49-53. 
100. Vucelic B, Korac B, Sentie M, et al. Epidemiology of Crohns-
Disease in Zagreb, Yugoslavia - a 10-Year Prospective-Study. 
/nt J Epidemiol 1991 ;20:216-20. 
101. Vucelic B, Korac B, Sentie M, et al. Ulcerative-colitis in Zagreb, 
Yugoslavia - incidence and prevalence 1980-1989. /nt J 
Epidemiol 1991 ;20:1043-7. 
102. Bitter J, Zuvacova J. Crohn's disease in the Northern Bohemian 
Region. Cesk Gastroenterol Vyz 1981 ;35:137-44. 
Please cite this article as: Juillerat P, et al, Prevalence of lnflammatory Bowet Disease in the Canton of Vaud (Switzerland): A population-
based cohort study, J Crohn's Colitis (2007), 
